Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115870372 | 11587037 | 2 | F | 2012 | 20160829 | 20151001 | 20160906 | EXP | US-ASTRAZENECA-2015SE92628 | ASTRAZENECA | 57.00 | YR | M | Y | 81.60000 | KG | 20160906 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115870372 | 11587037 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 UG 2 PUFFS TWICE DAILY | 21929 | BID | |||||||||
| 115870372 | 11587037 | 2 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 UG 2 PUFFS TWICE DAILY | 21929 | BID | |||||||||
| 115870372 | 11587037 | 3 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 UG 2 PUFFS TWICE DAILY | 21929 | BID | |||||||||
| 115870372 | 11587037 | 4 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 3 PUFFS AT ONCE ONCE/SINGLE ADMINISTRATION | 21929 | ||||||||||
| 115870372 | 11587037 | 5 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 3 PUFFS AT ONCE ONCE/SINGLE ADMINISTRATION | 21929 | ||||||||||
| 115870372 | 11587037 | 6 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 3 PUFFS AT ONCE ONCE/SINGLE ADMINISTRATION | 21929 | ||||||||||
| 115870372 | 11587037 | 7 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 1 PUFF TWICE DAILY ONCE/SINGLE ADMINISTRATION | 21929 | BID | |||||||||
| 115870372 | 11587037 | 8 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 1 PUFF TWICE DAILY ONCE/SINGLE ADMINISTRATION | 21929 | BID | |||||||||
| 115870372 | 11587037 | 9 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 1 PUFF TWICE DAILY ONCE/SINGLE ADMINISTRATION | 21929 | BID | |||||||||
| 115870372 | 11587037 | 10 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | ONCE DAILY ONCE/SINGLE ADMINISTRATION | 21929 | QD | |||||||||
| 115870372 | 11587037 | 11 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | ONCE DAILY ONCE/SINGLE ADMINISTRATION | 21929 | QD | |||||||||
| 115870372 | 11587037 | 12 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | ONCE DAILY ONCE/SINGLE ADMINISTRATION | 21929 | QD | |||||||||
| 115870372 | 11587037 | 13 | C | SUBOXONE | BUPRENORPHINE HYDROCHLORIDENALOXONE HYDROCHLORIDE | 1 | Topical | 2 STRIPS DAILY | 0 | ||||||||||
| 115870372 | 11587037 | 14 | C | SUBOXONE | BUPRENORPHINE HYDROCHLORIDENALOXONE HYDROCHLORIDE | 1 | Topical | 2 STRIPS DAILY | 0 | ||||||||||
| 115870372 | 11587037 | 15 | C | ALPRAZOLAM ER | ALPRAZOLAM | 1 | 0 | 3 | MG | QD | |||||||||
| 115870372 | 11587037 | 16 | C | TIZANIDINE HCL | TIZANIDINE HYDROCHLORIDE | 1 | Oral | 0 | 4 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115870372 | 11587037 | 1 | Emphysema |
| 115870372 | 11587037 | 2 | Chronic obstructive pulmonary disease |
| 115870372 | 11587037 | 3 | Asthma |
| 115870372 | 11587037 | 4 | Emphysema |
| 115870372 | 11587037 | 5 | Chronic obstructive pulmonary disease |
| 115870372 | 11587037 | 6 | Asthma |
| 115870372 | 11587037 | 7 | Emphysema |
| 115870372 | 11587037 | 8 | Chronic obstructive pulmonary disease |
| 115870372 | 11587037 | 9 | Asthma |
| 115870372 | 11587037 | 10 | Emphysema |
| 115870372 | 11587037 | 11 | Chronic obstructive pulmonary disease |
| 115870372 | 11587037 | 12 | Asthma |
| 115870372 | 11587037 | 13 | Pain |
| 115870372 | 11587037 | 14 | Drug dependence |
| 115870372 | 11587037 | 15 | Panic attack |
| 115870372 | 11587037 | 16 | Muscle spasms |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115870372 | 11587037 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115870372 | 11587037 | Craniocerebral injury | |
| 115870372 | 11587037 | Drug dose omission | |
| 115870372 | 11587037 | Intentional product misuse | |
| 115870372 | 11587037 | Memory impairment | |
| 115870372 | 11587037 | Product quality issue | |
| 115870372 | 11587037 | Pulmonary haemorrhage | |
| 115870372 | 11587037 | Rib fracture | |
| 115870372 | 11587037 | Road traffic accident | |
| 115870372 | 11587037 | Traumatic lung injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115870372 | 11587037 | 1 | 2008 | 201509 | 0 | |
| 115870372 | 11587037 | 2 | 2008 | 201509 | 0 | |
| 115870372 | 11587037 | 3 | 2008 | 201509 | 0 | |
| 115870372 | 11587037 | 13 | 201405 | 0 | ||
| 115870372 | 11587037 | 14 | 201405 | 0 | ||
| 115870372 | 11587037 | 15 | 201405 | 0 | ||
| 115870372 | 11587037 | 16 | 201405 | 0 |